BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu X, Ma J, Huang L, Zhu W, Yuan P, Wan R, Hong K. Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e8273. [PMID: 29095256 DOI: 10.1097/MD.0000000000008273] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Assimon MM, Pun PH, Wang LC, Al-Khatib SM, Brookhart MA, Weber DJ, Winkelmayer WC, Flythe JE. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol 2021. [PMID: 34668928 DOI: 10.1001/jamacardio.2021.4234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Shahbazi F, Shojaei L, Farvadi F, Kadivarian S. Antimicrobial safety considerations in critically ill patients: part II: focused on anti-microbial toxicities. Expert Rev Clin Pharmacol 2022;:1-11. [PMID: 35734938 DOI: 10.1080/17512433.2022.2093716] [Reference Citation Analysis]
3 Gorelik E, Masarwa R, Perlman A, Rotshild V, Abbasi M, Muszkat M, Matok I. Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis. Drug Saf 2019;42:529-38. [PMID: 30368737 DOI: 10.1007/s40264-018-0751-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
4 Liu M, Mei K, Liu X, Zhao Y. Impact of body mass index on procedural complications, procedure duration, and radiation dose in patients with atrial fibrillation undergoing radiofrequency ablation: A systematic review and meta-analysis. Clin Cardiol 2020;43:1067-75. [PMID: 32492246 DOI: 10.1002/clc.23398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Yurre AR, Silva JDFD, Torres MKDS, Martins EL, Ramos IP, Silva WSFLD, Sarpa JDS, Guedes CCDS, Napoleão TH, Coelho LCBB, Paiva PMG, Medei E. Evaluation of the Cardiac Effects of a Water-Soluble Lectin (Wsmol) from Moringa Oleifera Seeds. Arq Bras Cardiol 2020;114:1029-37. [PMID: 32187285 DOI: 10.36660/abc.20190071] [Reference Citation Analysis]
6 Weiner M, Gelfond J, Johnson-Pais TL, Engle M, Peloquin CA, Johnson JL, Sizemore EE, Mac Kenzie WR. Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother 2018;62:e01802-17. [PMID: 29463526 DOI: 10.1128/AAC.01802-17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Baggio D, Ananda-Rajah MR. Fluoroquinolone antibiotics and adverse events. Aust Prescr 2021;44:161-4. [PMID: 34728881 DOI: 10.18773/austprescr.2021.035] [Reference Citation Analysis]
8 Bystricky W, Maier C, Gintant G, Bergau D, Carter D. Identification of Drug-Induced Multichannel Block and Proarrhythmic Risk in Humans Using Continuous T Vector Velocity Effect Profiles Derived From Surface Electrocardiograms. Front Physiol 2020;11:567383. [PMID: 33071822 DOI: 10.3389/fphys.2020.567383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Long C, Liu X, Xiong Q, Su Y, Hong K. Sex Differences in Dilated Cardiomyopathy Prognosis: A Systematic Review and Meta-analysis. Int Heart J 2022;63:36-42. [DOI: 10.1536/ihj.20-448] [Reference Citation Analysis]
10 Sethi NJ, Safi S, Korang SK, Hróbjartsson A, Skoog M, Gluud C, Jakobsen JC. Antibiotics for secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2021;2:CD003610. [PMID: 33704780 DOI: 10.1002/14651858.CD003610.pub4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Liu X, Wang W, Tan Z, Zhu X, Liu M, Wan R, Hong K. The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies. Nutr J 2019;18:73. [PMID: 31727055 DOI: 10.1186/s12937-019-0485-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
12 Matoi A, Taguchi M, Nishi S. Fatal hypoglycemia with ciprofloxacin in a dialysis patient: A case report. Clin Case Rep 2021;9:1902-4. [PMID: 33936612 DOI: 10.1002/ccr3.3871] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Goodman KE, Cosgrove SE, Pineles L, Magder LS, Anderson DJ, Dodds Ashley E, Polk RE, Quan H, Trick WE, Woeltje KF, Leekha S, Harris AD. Significant Regional Differences in Antibiotic Use Across 576 US Hospitals and 11 701 326 Adult Admissions, 2016-2017. Clin Infect Dis 2021;73:213-22. [PMID: 32421195 DOI: 10.1093/cid/ciaa570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Yang PC, DeMarco KR, Aghasafari P, Jeng MT, Dawson JRD, Bekker S, Noskov SY, Yarov-Yarovoy V, Vorobyov I, Clancy CE. A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm. Circ Res 2020;126:947-64. [PMID: 32091972 DOI: 10.1161/CIRCRESAHA.119.316404] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 14.5] [Reference Citation Analysis]
15 Mathews B, Thalody AA, Miraj SS, Kunhikatta V, Rao M, Saravu K. Adverse Effects of Fluoroquinolones: A Retrospective Cohort Study in a South Indian Tertiary Healthcare Facility. Antibiotics (Basel) 2019;8:E104. [PMID: 31357640 DOI: 10.3390/antibiotics8030104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Aspinall SL, Sylvain NP, Zhao X, Zhang R, Dong D, Echevarria K, Glassman PA, Goetz MB, Miller DR, Cunningham FE. Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self-controlled case series analysis. Pharmacol Res Perspect 2020;8:e00664. [PMID: 33047487 DOI: 10.1002/prp2.664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Liu X, Long C, Xiong Q, Chen C, Ma J, Su Y, Hong K. Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID-19, inflammation level, severity, and death in patients with COVID-19: A rapid systematic review and meta-analysis. Clin Cardiol 2020. [PMID: 32757246 DOI: 10.1002/clc.23421] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
18 Hangas A, Aasumets K, Kekäläinen NJ, Paloheinä M, Pohjoismäki JL, Gerhold JM, Goffart S. Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2. Nucleic Acids Res 2018;46:9625-36. [PMID: 30169847 DOI: 10.1093/nar/gky793] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 12.3] [Reference Citation Analysis]
19 Alhamed Alduihi F. ECG Abnormalities in Patients with Acute Exacerbation of Bronchiectasis and Factors Associated with High Probability of Abnormality. Pulm Med 2021;2021:6649572. [PMID: 34327019 DOI: 10.1155/2021/6649572] [Reference Citation Analysis]